Stephens Consulting, LLC Summit Therapeutics Inc. Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
A detailed history of Stephens Consulting, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Stephens Consulting, LLC holds 20 shares of SMMT stock, worth $552. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$552% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
239Shares Held
87.2MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$674 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$321 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$218 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$181 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$134 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $5.55B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...